APA

Martirosov D. M., Bidell M. R., Pai M. P., Scheetz M. H., Rosenkranz S. L., Faragon C., Malik M., Mendes R. E., Jones R. N., McNutt L. & Lodise T. P. (20171023). Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. : BMC infectious diseases.

Chicago

Martirosov Dmitriy M, Bidell Monique R, Pai Manjunath P, Scheetz Marc H, Rosenkranz Susan L, Faragon Corey, Malik M, Mendes R E, Jones R N, McNutt Louise-Anne and Lodise Thomas P. 20171023. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. : BMC infectious diseases.

Harvard

Martirosov D. M., Bidell M. R., Pai M. P., Scheetz M. H., Rosenkranz S. L., Faragon C., Malik M., Mendes R. E., Jones R. N., McNutt L. and Lodise T. P. (20171023). Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. : BMC infectious diseases.

MLA

Martirosov Dmitriy M, Bidell Monique R, Pai Manjunath P, Scheetz Marc H, Rosenkranz Susan L, Faragon Corey, Malik M, Mendes R E, Jones R N, McNutt Louise-Anne and Lodise Thomas P. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study. : BMC infectious diseases. 20171023.